- Home
- ABVC vs CRIS Comparison
ABVC vs CRIS Comparison
Compare ABVC & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABVC
- CRIS
- Stock Information
- Founded
- ABVC 2015
- CRIS 2000
- Country
- ABVC United States
- CRIS United States
- Employees
- ABVC N/A
- CRIS N/A
- Industry
- ABVC Biotechnology: Pharmaceutical Preparations
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ABVC Health Care
- CRIS Health Care
- Exchange
- ABVC Nasdaq
- CRIS Nasdaq
- Market Cap
- ABVC 22.1M
- CRIS 21.3M
- IPO Year
- ABVC N/A
- CRIS 2000
- Fundamental
- Price
- ABVC $4.20
- CRIS $1.88
- Analyst Decision
- ABVC
- CRIS Strong Buy
- Analyst Count
- ABVC 0
- CRIS 2
- Target Price
- ABVC N/A
- CRIS $16.50
- AVG Volume (30 Days)
- ABVC 571.3K
- CRIS 153.9K
- Earning Date
- ABVC 08-13-2025
- CRIS 07-31-2025
- Dividend Yield
- ABVC N/A
- CRIS N/A
- EPS Growth
- ABVC N/A
- CRIS N/A
- EPS
- ABVC N/A
- CRIS N/A
- Revenue
- ABVC $508,383.00
- CRIS $11,202,000.00
- Revenue This Year
- ABVC $735.18
- CRIS N/A
- Revenue Next Year
- ABVC N/A
- CRIS $10.67
- P/E Ratio
- ABVC N/A
- CRIS N/A
- Revenue Growth
- ABVC 1904.43
- CRIS 14.17
- 52 Week Low
- ABVC $0.40
- CRIS $1.02
- 52 Week High
- ABVC $5.48
- CRIS $8.29
- Technical
- Relative Strength Index (RSI)
- ABVC 74.35
- CRIS 41.14
- Support Level
- ABVC $2.16
- CRIS $1.50
- Resistance Level
- ABVC $5.48
- CRIS $1.90
- Average True Range (ATR)
- ABVC 0.43
- CRIS 0.20
- MACD
- ABVC 0.23
- CRIS -0.06
- Stochastic Oscillator
- ABVC 64.84
- CRIS 35.51
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.